The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 36.00, with a high estimate of 65.00 and a low estimate of 23.00. The median estimate represents a +52.03% increase from the last price of 23.68.
The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.34
Reporting Date Aug 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.